Page last updated: 2024-09-03

imatinib mesylate and Adult-Onset Still Disease

imatinib mesylate has been researched along with Adult-Onset Still Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akashi, K; Harada, M; Henzan, H; Miyamoto, T; Nagafuji, K; Nagasaki, Y	1

Other Studies

1 other study(ies) available for imatinib mesylate and Adult-Onset Still Disease

Article	Year
Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia. The Journal of rheumatology, 2009, Volume: 36, Issue:6 Topics: Adult; Benzamides; Drug Resistance; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Still's Disease, Adult-Onset; Treatment Outcome	2009

Article

Year

Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia.

The Journal of rheumatology, 2009, Volume: 36, Issue:6

Topics: Adult; Benzamides; Drug Resistance; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Still's Disease, Adult-Onset; Treatment Outcome

2009